Paper30181583
Targeting the TLR4-MD2 axis in systemic sclerosis.
O'Reilly S and 1 other. Nat Rev Rheumatol, 2018. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Targeting the TLR4-MD2 axis in systemic sclerosis. Papers, record 30181583. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30181583
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Scleroderma, Systemic | Major topic |
| Toll-Like Receptor 4 | Major topic |
| Fibroblasts | |
| Fibrosis | |
| Humans | |
| Lipopolysaccharides | |
| Skin |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 29997297 | TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung. | https://conductscience.org/library/papers/29997297 |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23141927 | Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. | Am J Pathol | 2013 | https://conductscience.org/library/papers/23141927 | PubMed |
| 2 | 23512062 | Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. | JAMA | 2013 | https://conductscience.org/library/papers/23512062 | PubMed |
| 3 | 29997297 | TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung. | JCI Insight | 2018 | https://conductscience.org/library/papers/29997297 | PubMed |
| 4 | 18648520 | Molecular subsets in the gene expression signatures of scleroderma skin. | PLoS One | 2008 | https://conductscience.org/library/papers/18648520 | PubMed |
| 5 | 21900368 | Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. | Rheumatology (Oxford) | 2012 | https://conductscience.org/library/papers/21900368 | PubMed |
| 6 | 19252480 | The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. | Nature | 2009 | https://conductscience.org/library/papers/19252480 | PubMed |
| 7 | 28888416 | Toll Like Receptors in systemic sclerosis: An emerging target. | Immunol Lett | 2018 | https://conductscience.org/library/papers/28888416 | PubMed |
| 8 | 26159672 | Role of innate immune system in systemic sclerosis. | Semin Immunopathol | 2015 | https://conductscience.org/library/papers/26159672 | PubMed |
| 9 | 27256716 | Tenascin-C drives persistence of organ fibrosis. | Nat Commun | 2016 | https://conductscience.org/library/papers/27256716 | PubMed |
| 10 | 28116578 | Innate Immunity in Systemic Sclerosis. | Curr Rheumatol Rep | 2017 | https://conductscience.org/library/papers/28116578 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42349051 | Physical continuity at biomaterial-ECM interfaces is associated with reduced fibroblast activation and NF-κB signaling. | Biomaterials | 2026 | https://conductscience.org/library/papers/42349051 | PubMed |
| 39635531 | Prevalence of hybrid TLR4+M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung disease. | Front Immunol | 2024 | https://conductscience.org/library/papers/39635531 | PubMed |
| 39413786 | Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target. | Cell | 2024 | https://conductscience.org/library/papers/39413786 | PubMed |
| 34367191 | Extracellular CIRP Induces an Inflammatory Phenotype in Pulmonary Fibroblasts via TLR4. | Front Immunol | 2021 | https://conductscience.org/library/papers/34367191 | PubMed |
| 34346026 | Novel role of long non-coding RNAs in autoimmune cutaneous disease. | J Cell Commun Signal | 2022 | https://conductscience.org/library/papers/34346026 | PubMed |
| 32130706 | The Metabolic Remodelling in Lung Cancer and Its Putative Consequence in Therapy Response. | Adv Exp Med Biol | 2020 | https://conductscience.org/library/papers/32130706 | PubMed |
| 31123840 | Macrophages in Systemic Sclerosis: Novel Insights and Therapeutic Implications. | Curr Rheumatol Rep | 2019 | https://conductscience.org/library/papers/31123840 | PubMed |
| 30953351 | C1q/TNF-related protein-9 promotes macrophage polarization and improves cardiac dysfunction after myocardial infarction. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/30953351 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| LY96 | 23643 | PubTator's text mining | https://conductscience.org/library/genes/23643 | NCBI Gene |
| TLR4 | 7099 | PubTator's text mining | https://conductscience.org/library/genes/7099 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30181583
GET https://conductscience.org/api/papers/v1/30181583/authors